Emergent BioSolutions
EBS
#6766
Rank
NZ$1.09 B
Marketcap
NZ$20.60
Share price
-1.24%
Change (1 day)
33.49%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2025 (TTM): NZ$2.47

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is NZ$2.44. In 2024 the company made an earnings per share (EPS) of NZ-$6.28 an increase over its 2023 EPS that were of NZ-$25.76.

EPS history for Emergent BioSolutions from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$2.47-139.33%
2024NZ-$6.28-75.61%
2023NZ-$25.76232.21%
2022NZ-$7.75-203.46%
2021NZ$7.50-25.09%
2020NZ$10.01445.28%
2019NZ$1.83-15.2%
2018NZ$2.16-35.9%
2017NZ$3.3869.57%
2016NZ$1.99-27.67%
2015NZ$2.7565.63%
2014NZ$1.6611.63%
2013NZ$1.4932.31%
2012NZ$1.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Merck
MRK
NZ$13.14 438.57%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.73-70.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.22 155.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
NZ-$5.85-339.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.98 21.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.09-55.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
NZ-$5.61-329.79%๐Ÿ‡บ๐Ÿ‡ธ USA